Botanix Pharmaceuticals Ltd (ASX: BOT) Share Price and News
Price
–
Movement
– ( )
(20 mins delayed)
52 Week Range
– - –
1 Year Return
Botanix Pharmaceuticals Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$889.04 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
1.95 billion
Earnings per share
-0.022
Dividend per share
N/A
Year To Date Return
3.45%
Earnings Yield
N/A
Franking
-
Share Price
–
Day Change
– ( )
52 Week Range
– - –
Yesterday's Close
–
Today's Open
–
Days Range
– - –
Volume
–
Avg. Volume (1 month)
–
Turnover
–
Botanix Pharmaceuticals Ltd (ASX: BOT)
Latest News
Cannabis Shares
Why are these 2 ASX cannabis stocks sputtering today?
Share Fallers
Why Botanix, Nick Scali, Resolute, and Sayona Mining shares are dropping
Cannabis Shares
Guess which ASX cannabis share is crashing 36% following an FDA blow
Cannabis Shares
Could ASX cannabis shares be set for a resurgence?
Cannabis Shares
This ASX cannabis stock is up 160% since June, and it has an FDA ruling coming up!
Healthcare Shares
Here's why the Botanix (ASX:BOT) share price is slipping today
Cannabis Shares
Blazing it? How the top ASX cannabis shares performed in FY21
Share Gainers
The Botanix (ASX:BOT) share price jumped 20% today
Share Market News
What's with the Botanix (ASX:BOT) share price today?
Share Market News
Botanix (ASX:BOT) share price falls despite big tax refund
Share Gainers
Why the Botanix (ASX:BOT) share price is rocketing 31% higher today
Share Market News
Why the Botanix (ASX:BOT) share price is flying 6%
BOT ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|
About Botanix Pharmaceuticals Ltd
Botanix Pharmaceuticals Ltd is a dermatology company. The company focuses on developing safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1204 - Atopic Dermatitis, and BTX 1702 - Rosacea, Sofdra - Axillary Hyperhidrosis, and others. The majority of Revenue is Derived from Australia.
BOT Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 01 May 2025 | $0.45 | $-0.01 | -2.22% | 9,919,533 | $0.46 | $0.46 | $0.42 |
| 30 Apr 2025 | $0.45 | $0.01 | 2.27% | 10,890,639 | $0.45 | $0.46 | $0.43 |
| 29 Apr 2025 | $0.44 | $0.04 | 9.88% | 7,963,814 | $0.41 | $0.45 | $0.41 |
| 28 Apr 2025 | $0.41 | $-0.02 | -4.76% | 5,983,154 | $0.43 | $0.44 | $0.41 |
| 24 Apr 2025 | $0.42 | $-0.01 | -2.35% | 10,701,984 | $0.42 | $0.44 | $0.40 |
| 23 Apr 2025 | $0.43 | $0.03 | 7.59% | 6,938,022 | $0.41 | $0.43 | $0.41 |
| 22 Apr 2025 | $0.40 | $0.00 | 0.00% | 4,690,366 | $0.40 | $0.41 | $0.39 |
| 17 Apr 2025 | $0.40 | $0.01 | 2.60% | 5,382,654 | $0.39 | $0.40 | $0.38 |
| 16 Apr 2025 | $0.39 | $0.01 | 2.67% | 8,690,711 | $0.38 | $0.39 | $0.37 |
| 15 Apr 2025 | $0.38 | $0.02 | 5.63% | 16,096,668 | $0.36 | $0.40 | $0.36 |
| 11 Apr 2025 | $0.36 | $-0.02 | -5.41% | 6,543,237 | $0.37 | $0.37 | $0.35 |
| 10 Apr 2025 | $0.37 | $0.02 | 5.71% | 12,841,932 | $0.42 | $0.42 | $0.37 |
| 09 Apr 2025 | $0.35 | $-0.02 | -5.41% | 14,651,649 | $0.36 | $0.37 | $0.34 |
| 08 Apr 2025 | $0.37 | $0.01 | 2.78% | 9,900,873 | $0.37 | $0.38 | $0.36 |
| 07 Apr 2025 | $0.36 | $-0.04 | -10.00% | 22,058,309 | $0.38 | $0.38 | $0.34 |
| 04 Apr 2025 | $0.40 | $-0.03 | -7.06% | 7,860,709 | $0.42 | $0.42 | $0.40 |
| 03 Apr 2025 | $0.43 | $-0.02 | -4.55% | 6,314,483 | $0.44 | $0.44 | $0.41 |
| 02 Apr 2025 | $0.44 | $-0.01 | -2.22% | 6,952,261 | $0.45 | $0.46 | $0.44 |